Repligen | RGEN - 员工总数

金融业

USD

USD 2.95B

现金及等价物

USD 606.78M

USD 94.09M

USD 1.2B

USD 132.66M

USD 546.59M

USD 21.13M

USD 43.77M

1.78K

EPS每股收益

USD 0.54

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 551.05M

USD 7.86B

USD 5.01M

USD 183M

USD 21.13M

普通股股本

USD 56.43M

105.09

USD 1.77M

USD 204M

销售和管理费用

USD 76.62M

USD 186.6M

贸易债权人

USD 33.23M

应收帐款人

USD 157.71M

	员工	更改		日
Agilent	17.9K		200	2024-10
Align Technology	20.94K		665	2024-12
Bio Techne	3.1K		50	2024-06
BioMarin Pharmaceutical	3.04K		361	2024-12
Bristol-Myers Squibb	34.1K		0	2024-12
Bruker	9.71K		1.18K	2023-12
Charles River Laboratories	18.6K		1.4K	2024-12
Danaher	61K		18K	2023-12
Dentsply International	14K		1000	2024-12
General Electric Aerospace	57K		4K	2025-12
Henry Schein	25K		0	2024-12
Illumina	8.97K		1.62K	2024-12
IQVIA Holdings	88K		1000	2024-12
Mettler Toledo International	16K		400	2023-12
Myriad Genetics	2.7K		0	2024-12
OraSure Technologies	638		202	2023-12
Pacific Biosciences Of California	796		27	2023-12
Pfizer	81K		7K	2024-12
Repligen	1.78K		5	2024-12
Revvity	11K		500	2024-12
Standard Biotools	534		11	2023-12
Thermo Fisher Scientific	125K		3K	2024-12
Waters	7.6K		300	2024-12
West Pharmaceutical Services	10.6K		0	2024-12